ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Enovis CORP

Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 6, 2026

$19.87+0.28 (+1.43%)

Close on Oct 19, 2026

Market cap: $1.14B
P/E (TTM): –
Dividend yield: –

Enovis CORP income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	2,248	2,108	1,707	1,563	1,426	1,121	3,327	2,193	1,937	3,186	3,434	4,624	4,207	3,914	693	542	525
Cost of Revenue	903	927	716	694	649	517	1,926	1,464	1,266	2,193	2,363	3,146	2,901	2,762	453	351	339
Gross Profit	1,345	1,181	991	869	778	604	1,401	729	672	992	1,072	1,479	1,306	1,152	240	191	186
Research & Development	120	91	75	61	49	34	–	–	–	–	–	–	–	–	5.71	6.21	5.93
Selling, General & Admin	1,070	1,027	830	773	666	515	1,132	549	501	697	748	1,011	864	908	163	134	113
Operating Income	-1,124	-776	-66	-71	-63	-66	204	152	136	237	266	410	406	140	26	34	40
Interest Expense	35	57	20	24	29	53	120	49	40	30	48	51	104	92	5.92	6.68	7.21
Income from Equity Investments	-0.60	-0.60	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	-0.37	9.90	26	2.09	0	–	–	–	–	–	–	–	–	–	–	–	–
Merger & Restructuring Charges	9.79	27	17	17	8.69	17	65	29	68	58	57	58	36	60	9.68	10	18
Asset Impairment Charges	1,050	650	0	0	–	1.60	0	7.09	184	6.08	13	–	–	–	–	–	–
Gain (Loss) on Investments	–	0	0	103	0	0	0	-10	0	0	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-1.46	-1.22	15	-0.35	2.57	0.49	-0.06	21	11	-0.53	0	–	–	–	-0.68	-0.09	0.06
Legal Settlements	–	0	0	37	0	0	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	-1,159	-823	-67	-2.07	-122	-119	50	92	49	207	218	358	303	48	20	28	32
Income Tax Expense	22	4.49	-13	36	-20	-45	32	-30	2.48	52	41	-62	94	91	15	11	8.62
Income from Continuing Operations	-1,182	-827	-54	-38	-102	-74	19	122	46	–	–	–	–	–	–	–	–
Income from Discontinued Operations	-1.91	2.60	21	26	179	120	-536	33	123	-9.56	10	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	-1,184	-825	-33	-12	76	46	-517	154	170	145	187	420	209	-42	4.56	16	–
Minority Interest in Earnings	–	–	–	–	4.62	3.15	11	14	18	17	19	28	31	22	0	0	–
Net Income	-1,184	-825	-33	-13	72	43	-528	140	151	128	168	392	179	-64	4.56	16	24
Preferred Dividends	–	–	–	–	–	–	–	–	–	–	–	2.35	20	19	–	–	–
Net Income to Common	–	–	–	–	–	–	–	169	45	138	158	370	158	-83	4.56	16	–
EPS (Basic)(per share)	-20.75	-14.93	-0.61	-0.25	1.40	0.93	-11.67	3.51	3.69	3.12	4.05	9.18	4.68	-2.76	0.30	1.11	1.65
EPS (Diluted)(per share)	-20.75	-14.93	-0.61	-0.25	1.40	0.93	-11.67	3.48	3.66	3.12	4.02	9.06	4.62	-2.76	0.30	1.11	1.65
Shares Outstanding (Basic, Weighted)(shares)	57	55	54	54	51	46	45	40	41	41	41	40	33	30	15	14	–
Shares Outstanding (Diluted, Weighted)(shares)	57	55	54	54	51	46	46	40	41	41	42	41	33	30	15	15	–
EBITDA	220	152	151	132	124	102	419	233	208	366	403	584	526	323	49	51	–
Provision for Credit Losses	3.03	11	-4.84	2.55	2.55	7.57	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 3, 2026

Profitability, TTM

Gross margin: 61.1%
Operating margin: -45.1%
Net margin: -48.0%
Return on equity, FY2025: -58.5%

Financial strength

Current ratio: 1.98
Debt to equity: 0.87
Debt to assets: 34.1%
Cash to current liabilities: 2.1%

Valuation

P/E ratio: –
Price to sales: 0.50
Price to book: 0.77
Dividend yield: –